By Tim Schwab
In the great debate over genetically engineered (GE) salmon, the Food & Drug Administration (FDA) has locked the public out of key discussions by failing to disclose critical information related to the still-pending regulatory approval. As we wait to hear if the FDA will approve GE salmon this summer, we continue to scratch our heads at the contradictions that FDA can’t — or won’t — explain.
Since the FDA first publicized its review of GE salmon in 2010, independent sources have uncovered document after document that contradict the agency’s glowing findings that the fish is safe to eat, safe to produce, and a solution for fish farmers.
In an attempt to reconcile the striking differences between what the FDA is telling the public and what independent sources are saying, Food & Water Watch has filed numerous Freedom of Information Act (FOIA) requests with the FDA since 2010.
The FDA has been silent, rejecting or sitting on requests for years. Other groups filing FOIAs have been met with the same silence.
Almost exactly one year ago, Food & Water Watch asked the agency for documents related to a major biosecurity breach we discovered at AquaBounty Technologies’ proposed GE-salmon production facility. We found a corporate document from 2008 that said an “unusually severe storm” lead to “lost” GE salmon.
In an effort to understand how FDA failed to discover or disclose this major event, which presents crucial risk-assessment questions related to potential environmentally damaging escapes, we filed a FOIA request, asking the agency for all documents it had related to the “lost” salmon event. Thus far, the FDA has failed to respond.